Hepatocyte nuclear factor 4α – prospects for therapeutic targeting

Yusuke Inoue

doi:10.1080/14728222.2026.2690135

June 25, 2026Expert Opinion on Therapeutic Targets

Hepatocyte nuclear factor 4α – prospects for therapeutic targeting

View Full Paper

Ask AI

Bookmark

Share

Key Points

The research aims to explore the therapeutic potential of targeting HNF4α for treating liver and pancreatic disorders.
Review of current literature on HNF4α functions and expression
Analysis of therapeutic strategies focusing on HNF4α
Evaluation of potential interventions using clinical and laboratory data
HNF4α is significantly involved in gene regulation in hepatocytes and pancreatic β cells.
Targeting HNF4α shows promise in improving metabolic functions and disease outcomes.
Emerging therapies could lead to novel treatment options for metabolic liver diseases.

Implication

Demonstrates therapeutic targeting of HNF4α for gene regulation in hepatic and pancreatic cells, suggesting potential for innovative treatments.

Abstract

Hepatocyte nuclear factor 4α (HNF4α), a member of the nuclear receptor superfamily, is highly expressed in hepatocytes of the liver, pancreatic β cells, epithelial cells of the small intestine a...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yusuke Inoue (2026) studied this question.

synapsesocial.com/papers/6a3f68cdaea7db3c1953fbd4 https://doi.org/10.1080/14728222.2026.2690135

View Full Paper

Ask AI

Bookmark

Share

Hepatocyte nuclear factor 4α – prospects for therapeutic targeting

Key Points

Implication

Abstract

Discussion

Cite This Study

Hepatocyte nuclear factor 4α – prospects for therapeutic targeting

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading